Last update 12 Apr 2025

cαStx1/cαStx2

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms-
Target
Shiga toxin
Action
inhibitors
Mechanism
Shiga toxin inhibitors
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication-
Inactive Indication
Bacterial InfectionsDiarrhea
Originator Organization
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with cαStx1/cαStx2
NCT01252199
/ CompletedPhase 2
A Phase II Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 (cαStx1) and 2 (cαStx2) Administered Concomitantly to Children With Shiga Toxin-Producing Bacterial (STPB) Infection and Bloody Diarrhea (SHIGATEC Trial)
100 Clinical Results associated with cαStx1/cαStx2
Login to view more data
100 Translational Medicine associated with cαStx1/cαStx2
Login to view more data
100 Patents (Medical) associated with cαStx1/cαStx2
Login to view more data
100 Deals associated with cαStx1/cαStx2
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bacterial InfectionsPhase 2
Argentina
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
Bacterial InfectionsPhase 2
Chile
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
Bacterial InfectionsPhase 2
Peru
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
DiarrheaPhase 2
Argentina
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
DiarrheaPhase 2
Chile
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
DiarrheaPhase 2
Peru
Thallion Pharmaceuticals, Inc.Thallion Pharmaceuticals, Inc.
01 Nov 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free